Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational study

Incidence of adverse reaction of drugs used in COVID-19 management: a retrospective, observational study

Background: An urgent need for coronavirus infectious disease (COVID-19) treatment has resulted in off-label drug use. Although previous studies had investigated the adverse drug reaction (ADR) of the medications for COVID-19 in their respective local settings, the safety profile in a Malaysian sett...

Full description

Bibliographic Details
Main Authors: Ang, A.S.Y (Author), Ang, L.M (Author), Lee, J.Y (Author), Mohd Ali, N. (Author), Omar, A. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2021
Subjects:
abdominal pain
acute kidney failure
adult
Adverse drug reactions
anemia
anti-SARS-CoV-2 agent
Article
asthma
atazanavir
beta1b interferon
bradycardia
cardiovascular disease
causality
chloroquine
chronic kidney failure
chronic obstructive lung disease
Clinical pharmacy
comorbidity
controlled study
coronavirus disease 2019
diabetes mellitus
diarrhea
disease classification
disease severity
dizziness
drug hypersensitivity
Drug monitoring
drug safety
Drug safety
favipiravir
female
gastrointestinal disease
headache
heart disease
heart palpitation
hepatobiliary disease
human
hydroxychloroquine
hyperbilirubinemia
hypertension
hypertransaminasemia
incidence
jaundice
lopinavir plus ritonavir
major clinical study
Malaysia
male
malignant neoplasm
nausea and vomiting
obesity
observational study
off label drug use
Pharmaceutical care
QT prolongation
rash
retrospective study
ribavirin
risk factor
tertiary care center
tocilizumab
unspecified side effect
World Health Organization
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items